Retention time in monkey plasma assessed as radioactivity at 15 to 106 MBq of [(18)F]-(1-(8-(2-Fluoroethoxy)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)piperidin-4-yl)(4-fluorophenyl)methanone after 5 to 120 mins by HPLC analysis
Metabolic stability in monkey plasma assessed as radioactivity at 15 to 106 MBq of [(18)F]-(1-(8-(2-Fluoroethoxy)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)piperidin-4-yl)(4-fluorophenyl)methanone after 5 mins by HPLC analysis
Metabolic stability in monkey plasma assessed as radioactivity at 15 to 106 MBq of [(18)F]-(1-(8-(2-Fluoroethoxy)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)piperidin-4-yl)(4-fluorophenyl)methanone after 15 mins by HPLC analysis
Metabolic stability in monkey plasma assessed as radioactivity at 15 to 106 MBq of [(18)F]-(1-(8-(2-Fluoroethoxy)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)piperidin-4-yl)(4-fluorophenyl)methanone after 30 mins by HPLC analysis
Metabolic stability in monkey plasma assessed as radioactivity at 15 to 106 MBq of [(18)F]-(1-(8-(2-Fluoroethoxy)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)piperidin-4-yl)(4-fluorophenyl)methanone after 60 mins by HPLC analysis
Metabolic stability in monkey plasma assessed as radioactivity at 15 to 106 MBq of [(18)F]-(1-(8-(2-Fluoroethoxy)-3-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)piperidin-4-yl)(4-fluorophenyl)methanone after 90 mins by HPLC analysis